What's new AAPOS 2008 - The Private Eye Clinic

Verisyse intraocular lens implantation in a child with anisometropic amblyopia:
four-year follow-up.
Assil KK, Sturm JM, Chang SH.
J Cataract Refract Surg. 2007 Nov;33(11):1985-6.
A Verisyse phakic intraocular lens (pIOL) (AMO) was implanted in the eye of a 3-yearold
child with unilateral high myopia and suspected dense amblyopia. Four years
postoperatively, the Snellen visual acuity was 20/30 with a refraction of -1.00 -1.00 x 77
and the endothelial cell density was 3262 cells/mm(2) compared with 3092 cells/mm(2)
in the right eye. The Verisyse pIOL may be a treatment option to prevent dense
amblyopia in children with highly myopic anisometropia.
GLUED PATCHES FOR CHILDREN RESISTANT TO AMBLYOPIA OCCLUSION
THERAPY
A Case Report
Shehla Rubab MD MCPS FCPS (Pak); Dana French BSc OC(C); Alex V Levin MD
MHSc FRCSC
Arch Ophthalmol 2008;126(1):133-134
This was a pilot study for a novel approach to poor compliance to occlusion therapy;
specifically, cyanoacrylate glue applied to a patch to increase its adhesiveness so the
child could not easily remove it. Dermabond Glue (Ethicon Inc, Johnson & Johnson
Company, Sommerville, New Jersey) and Opticlude Junior patches (3M Company, St
Paul, Minnesota) were utilized in this study. Safety and adhesiveness were assed in
four adult volunteers. The glued patches were applied to the upper arm of 4 adult
volunteers (including the authors) for 1 week. Only one woman developed mild
erythema, which resolved without treatment.
Five children with monocular amblyopia in whom all attempts of occlusion therapy had
failed were recruited. The glue was applied to the adhesive part of the patch, and the
children wore it over the good eye for 1 week. The patch was removed in the clinic, and
after visual acuity and external examination, was reapplied in the same manner. After
four consecutive weeks, compliance improved gradually in all cases. Three children
developed mild erythema where the skin was in contact with the glue, but in all cases it
resolved without any treatment in less than 2 days.
The authors recognize this was a pilot study with a small sample size, and to better
understand the efficacy, risks, and suitability of glued patches, studies with larger
numbers of patients and various types of amblyopia should be undertaken.
53